Cargando…
Specific-class Skin Side-effects of Drugs Might Compromise Blinding in Randomized Controlled Trials
Autores principales: | DO-PHAM, Giao, MARUANI, Annabel, LEDUCQ, Sophie, GIRAUDEAU, Bruno, CHOSIDOW, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944189/ https://www.ncbi.nlm.nih.gov/pubmed/36789755 http://dx.doi.org/10.2340/actadv.v103.3364 |
Ejemplares similares
-
Designs used in published therapeutic studies of rare superficial vascular anomalies: a systematic literature search
por: Allemang-Trivalle, Aude, et al.
Publicado: (2023) -
High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug
por: Chosidow, Olivier, et al.
Publicado: (2018) -
Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial
por: Marchand, A., et al.
Publicado: (2022) -
Right-sided rhabdoid colorectal tumors might be related to the Serrated Pathway
por: Pancione, Massimo, et al.
Publicado: (2013) -
Lesion of the Anal Margin in a Young Child: A Quiz
por: LE HELLOCO, Claire, et al.
Publicado: (2022)